RxDoctor Payments Data

van Barros, NP

Nurse Practitioner · Denville, NJNPI 1932628104

Payments from drug & device makers

$1,017in general payments, 2019–2025

Across 44 payments — averaging $23.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$276
  • Astellas Pharma US Inc$160
  • AbbVie$100
  • Bayer$71
  • Merck$55
  • Boston Scientific$54
  • plus $300 from 11 others

What the payments were for

  • Food & beverage$71270%
  • Education$30530%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,017 in reported general payments places this provider in the 80th percentile of 2,138 nurse practitioner providers in New Jersey.

See all nurse practitioner providers in New Jersey

Medicare billing

Part B allowed, 2024
$26,915
Medicare patients
111
Services billed
1,117

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MyrbetriqMirabegron103$62,602
GemtesaVibegron29$10,169
Tamsulosin Hcl130$2,957
Solifenacin Succinate23$837
Finasteride39$450
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst26$435
Alfuzosin Hcl ErAlfuzosin Hcl14$364
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip15$209
Cephalexin33$174
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim33$143

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Astellas Pharma US IncMyrbetriq$160$62,602103 claims
Sumitomo Pharma America, Inc.Gemtesa$51$10,16929 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 2,138 nurse practitioner providers in New Jersey.

Other nurse practitioner in Denville

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →